DENTSPLY SIRONA Inc. (XRAY) is a publicly traded Healthcare sector company. As of May 21, 2026, XRAY trades at $9.72 with a market cap of $1.97B and a P/E ratio of 1.92. XRAY moved +1.03% today. Year to date, XRAY is -15.25%; over the trailing twelve months it is -41.11%. Its 52-week range spans $9.41 to $27.44. Analyst consensus is neutral with an average price target of $13.88. Rallies surfaces XRAY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Dentsply Sirona Reports $880M Q1 Sales, 48.5% Gross Margin, Launches AI Diagnostic Tool: Dentsply Sirona reported Q1 net sales of $880 million, GAAP gross margin of 48.5%, GAAP net loss per share of $0.05 and adjusted EPS of $0.27. The company launched FDA-cleared AI diagnostic aid Smart View-Detect and confirmed guidance for $3.5B–$3.6B net sales and $1.40–$1.50 EPS.
| Metric | Value |
|---|---|
| Price | $9.72 |
| Market Cap | $1.97B |
| P/E Ratio | 1.92 |
| EPS | $5.19 |
| Dividend Yield | 0.16% |
| 52-Week High | $27.44 |
| 52-Week Low | $9.41 |
| Volume | 4 |
| Avg Volume | 0 |
| Revenue (TTM) | $24.78B |
| Net Income | $3.69B |
| Gross Margin | 58.94% |
14 analysts cover XRAY: 0 strong buy, 3 buy, 9 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $13.88.